Comparisons of peptide and oligonucleotide maps of glycoproteins and RNA from nine isolates of equine infectious anemia virus (EIAV) that were generated during parallel infections of two Shetland ponies revealed that each isolate was structurally unique. Each EIAV isolate contained a unique subset of variant peptides, oligonucleotides, or both, indicating that structural variation in EIAV is a random and noncumulative process and that a large spectrum of possible EIAV variants can be generated in infected animals.
The members of the lentivirus subfamily of retroviruses, including equine infectious anemia virus (EIAV), visna virus, and human immunodeficiency virus (HIV), cause chronic diseases in a variety of animals and humans (2, 5, 6, 8, 16) . The persistent infections caused by these viruses in some instances can be traced to their ability to circumvent or overcome the immune responses of the host (4, 6, 9, 18) . In the case of EIAV, which causes a unique episodic disease in horses, it has been demonstrated that isolates recovered from an infected animal during different febrile episodes can be distinguished antigenically and structurally by a variety of biochemical and immunological assays (11, 15, 18) . Results of these studies have indicated that structural and antigenic variation is localized to the envelope glycoproteins gp9O and gp45 (11, 18) . The occurrence of envelope glycoprotein variation has also been demonstrated for visna virus and HIV (1, 4, 7, 19) .
A critical question regarding lentivirus variation is the number of variants that can occur in nature, a major factor in assessing potential vaccines. To analyze the spectrum of structural variation among isolates of EIAV, we used peptide, glycopeptide, and oligonucleotide mapping procedures to compare nine EIAV isolates recovered during distinct clinical episodes in two ponies infected with the same virus.
To conduct these experiments, identical virulent virus inocula were used in parallel infections of two Shetland ponies as described previously (11, 13, 18) . The clinical histories of these animals are summarized in Fig. 1 . Plasma samples taken during clinical episodes were subjected to endpoint dilution in fetal equine kidney cells to recover the predominant virus population (13) . The nine EIAV isolates recovered were propagated in fetal equine kidney cells and purified by glycerol gradient centrifugation (10, 11, 14) . Each virus isolate was determined to be antigenically distinct by using a variety of immunoassays employing serum from infected ponies, panels of monoclonal antibodies, or both (18; A. Orrego, Ph.D. thesis, Louisiana State University, Baton Rouge, 1983 ).
The extent of structural variation in the viral glycoproteins gp9O and gp45 for each of the nine EIAV isolates was assayed by two-dimensional 125I-labeled tryptic peptide (11, a) 0. 18) and glycopeptide (17) mapping procedures. All peptide and glycopeptide patterns were reproducible on repeated mappings, and virus isolates remained stable during continued passage in tissue culture. Figure 2 shows the composite maps developed to display conserved and variant peptides for gp9O and gp45. A total of 54 peptides were identified on comparison of the gp9O component of the nine variants and the prototype strain of EIAV. Twenty-seven (50%) of the gp9O peptides were found to be common to all isolates. The pattern of variation of the remaining peptides was used to uniquely identify eight of nine variant strains, as well as the prototype strain of the virus ( In contrast to the envelope glycoproteins, the peptide maps for the viral core proteins p9, p15, and p26 were identical for all virus isolates (data not shQwn), as reported previously (11, 17) . gp9O and gp45 from each virus isolate were also analyzed by glycopeptide mapping to compare the glycosylated tryptic peptides not resolved by standard peptide mapping procedures (11, 17, 18) . Four classes of gp9O and two classes of gp45 glycopeptide patterns were observed. Representative glycopeptide maps are shown in Fig. 3 , and in Table 2 To analyze the genomic variation among EIAV isolates, RNA was purified from each virus and analyzed by oligonucleotide mapping by previously described techniques (15, 18) . A composite map showing conserved and variant oligonucleotides was then developed (Fig. 4) . A total of 51 oligonucleotides are represented in Fig. 4, and There appears to be a relatively large number of structural variations possible in EIAV. In addition to the nine virus isolates described here, we recovered five more EIAV isolates from a third pony that received the same initial virus inoculum (unpublished data). These virus isolates could also be distinguished structurally, bringing the total number of unique variants generated from this virus inoculum to 14. These 14 isolates were distinct from isolates recovered from independent serial transmissions of EIAV between ponies (11, 15) . Thus, a total of at least 17 distinct structural variants were cataloged in our laboratory. This large range of EIAV variation is similar to that observed for HIV, in which no two virus isolates examined have been found to be identical in restriction enzyme mapping, DNA sequencing studies, or both (1) . The evolution of EIAV variants during a persistent infection is evidently random; i.e., no predictable sequence of virus variation was observed in the two experimentally infected animals, although each animal received identical virus inocula. This result differs from the data reported for parallel persistent infections with visna virus, in which similar patterns of variant evolution were observed (3) . This difference may reflect that a larger spectrum of variation is possible in EIAV compared with visna virus. usually requires at least a year (12) , and the generation of HIV variants is believed to follow a similar time course (7) . In this regard, EIAV provides a unique model to study rapidly changing virus structure, as well as the dynamic interaction between host immune responses and evolving lentivirus antigens.
